Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort

American Journal of Epidemiology

Volumn 169, Issue 12, 2009, Pages 1492-1499

  Ma, Xiaomei ^a   Lim, Unhee ^b   Park, Yikyung ^c   Mayne, Susan T ^a   Wang, Rong ^a   Hartge, Patricia ^c   Hollenbeck, Albert R ^d   Schatzkin, Arthur ^c  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d AARP   (United States)

Author keywords

Life style; Myelodysplastic syndromes; Obesity; Smoking

Indexed keywords

ALCOHOL; BIOLOGICAL UPTAKE; BODY MASS; BODY SIZE; COHORT ANALYSIS; ETIOLOGY; HEALTH RISK; LIFESTYLE; OBESITY; PUBLIC HEALTH; RISK FACTOR; SMOKING;

ADULT; AGED; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OBESITY; RISK FACTOR; UNITED STATES; CONFIDENCE INTERVAL; EXERCISE; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING;

NORTH AMERICA; UNITED STATES;

AGED; BODY MASS INDEX; CONFIDENCE INTERVALS; EXERCISE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OBESITY; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; UNITED STATES;

EID: 67649226444     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp074     Document Type: Article

References (32)

1. Corey SJ, Minden MD, Barber DL, et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer. 2007;7(2):118-129.
2. Ma X, Does M, Raza A, et al. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007; 109(8):1536-1542.
3. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008;112(1):45-52.
4. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int J Cancer. 2008;122(6):1418-1421.
5. Larsson SC, Wolk A. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis. Int J Cancer. 2007;121(7): 1564-1570.
6. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007;335(7630):1134.
7. Pan SY, Johnson KC, Ugnat AM, et al. Association of obesity and cancer risk in Canada. Am J Epidemiol. 2004;159(3): 259-268.
8. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol. 2001;154(12):1119-1125.
9. Adams KF, Leitzmann MF, Albanes D, et al. Body mass and colorectal cancer risk in the NIH-AARP cohort. Am J Epidemiol. 2007;166(1):36-45.
10. Michaud DS, Midthune D, Hermansen S, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manage. 2005;32:70-75.
11. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology (ICD-O). Third Edition. Geneva, Switzerland: World Health Organization; 2000.
12. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51(2):189-199.
13. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17(12):3835-3849.
14. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292-2302.
15. World Health Organization. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. (WHO Technical Report Series no. 854). Geneva, Switzerland: World Health Organization; 1995.
16. Willett W. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
17. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
18. Nisse C, Lorthois C, Dorp V, et al. Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. Leukemia. 1995; 9(4):693-699.
19. Strom SS, Gu Y, Gruschkus SK, et al. Risk factors of myelodysplastic syndromes: a case-control study. Leukemia. 2005; 19(11):1912-1918.
20. Pasqualetti P, Festuccia V, Acitelli P, et al. Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol. 1997;97(3):659-662.
21. Nisse C, Haguenoer JM, Grandbastien B, et al. Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol. 2001;112(4): 927-935.
22. Björk J, Albin M, Mauritzson N, et al. Smoking and myelodysplastic syndromes. Epidemiology. 2000;11(3):285-291.
23. Ido M, Nagata C, Kawakami N, et al. A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res. 1996;20(9):727-731.
24. Dalamaga M, Petridou E, Cook FE, et al. Risk factors for myelodysplastic syndromes: a case-control study in Greece. Cancer Causes Control. 2002;13(7):603-608.
25. Miller KB. Myelodysplastic syndromes. In: Wiernik PH, Goldman JM, Dutcher JP, et al, eds. Neoplastic Diseases of the Blood. Cambridge, United Kingdom: Cambridge University Press; 2003:395-414.
26. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-591.
27. Shimon I, Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res. 1995;19(4):233-240.
28. Stevens J, Keil JE, Waid LR, et al. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol. 1990;132(6):1156-1163.
29. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68(4): 437-446.
30. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395(6704):763-770.
31. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000;96(12): 3671-3674.
32. McAdams MA, Van Dam RM, Hu FB. Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring). 2007;15(1):188-196.